In analysis of pancreatic cancer cells, the overexpression of N-cadherin promotes the EMT process through the activation of the ErbB signaling pathway, creating possible new therapeutic targets for pancreatic cancer cells [81]. This evidence concerns the gene CDH2 and pancreatic neoplasm.